Page last updated: 2024-08-24

fluorodeoxyglucose f18 and dactolisib

fluorodeoxyglucose f18 has been researched along with dactolisib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hussien, K; Kelly, CJ; Muschel, RJ	1

Other Studies

1 other study(ies) available for fluorodeoxyglucose f18 and dactolisib

Article	Year
3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition. Nuclear medicine and biology, 2012, Volume: 39, Issue:7 Topics: Aminopyridines; Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Feasibility Studies; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolines; Spheroids, Cellular; Time Factors; Treatment Outcome	2012

Article

Year

3D tumour spheroids as a model to assess the suitability of [18F]FDG-PET as an early indicator of response to PI3K inhibition.

Nuclear medicine and biology, 2012, Volume: 39, Issue:7

Topics: Aminopyridines; Animals; Biological Transport; Cell Line, Tumor; Cell Proliferation; Feasibility Studies; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Mice; Morpholines; Phosphoinositide-3 Kinase Inhibitors; Phosphoproteins; Positron-Emission Tomography; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinolines; Spheroids, Cellular; Time Factors; Treatment Outcome

2012